Tetraethylene glycol monohexadecyl ether, 98%, 1g

Oxion Inverso OX.2003-PL with LWD Plan 10x/20x/40x objectives

N-(3-((6-((3-(TRIFLUOROMETHYL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)PHENYL)CYCLOPROPANECARBOXAMIDE, 95%, 1mg

Polydimethylsiloxane, trimethylsiloxy terminated 1,000cSt, 100g

8-METHOXYQUINOLINE-3-CARBONITRILE, 95.0%, 250mg

1-indolizin-2-ylethanone, 95.0%, 250mg

3-Bromo-4-(propan-2-yloxy)aniline hydrochloride, 95%, 10g

5-AMINO-2(1H)-QUINOLINONE, 95.0%, 100mg

2,5-DIhydroxybenzoic acid butylamine salt, 98%, 1g

2-carboethoxy-4'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

Tert-butyl 6-((4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 98%, 500mg

N-(4-butylphenyl)-4-fluorobenzenesulfonamide, 98%, 1g

(R)-Methyl 2-(4-hydroxyphenoxy)propanoate, 95.0%, 25g